Item 4 — Purpose of Transaction
This Amendment amends and supplements Item 4 of the Original Schedule 13D by adding the following: Confirmatory Letter On August 6, 2026, the Consortium jointly submitted a confirmatory letter (the "Confirmatory Letter") to the Board to reaffirm the Cash Consideration of $7.02 per share set out in the Revised Proposal submitted by the Consortium on July 27, 2026, as its best and final non-binding offer and to confirm that the Consortium's due diligence exercise has been completed. The Confirmatory Letter further reaffirms that the Consortium is interested only in acquiring the Shares (on a fully diluted basis), and the Consortium does not intend to sell their Shares to any third party in any alternative takeover transaction. All other terms of the Revised Proposal and proposal made by the Consortium on May 28, 2026, including the Rollover, remain unchanged. The Confirmatory Letter is non-binding, and no agreement, arrangement or understanding between the Consortium, on the one hand, and the Issuer, on the other hand, relating to the Confirmatory Letter, the Proposed Transaction or any other transaction will be created until such time as definitive agreements for the Proposed Transaction have been executed and delivered. The Reporting Person does not intend to update this Schedule 13D to reflect developments relating to the Proposed Transaction except to the extent required by law. References to, and descriptions of, the Confirmatory Letter in this Schedule 13D are qualified in their entirety by the terms of the Confirmatory Letter, a copy of which is attached hereto as Exhibit 99.18 and is incorporated in its entirety into this Item 4.